A Systematic Review of the Effectiveness of Hospital- and Ambulatory-Based Management of Multidrug-Resistant Tuberculosis
Open Access
- 7 August 2013
- journal article
- review article
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 89 (2) , 271-280
Abstract
A systematic review of the literature was conducted on the effectiveness of MDR-TB management. A meta-analysis of treatment outcomes of patients treated in hospitals versus ambulatory-based models was performed in accordance with PRISMA guidelines. The pooled treatment success rate was 66.4% (95% confidence interval [CI] 61.4–71.1%), with no statistical difference between ambulatory (65.5%; 55.1–74.6%) and hospital-based models (66.7%; 61.0–72.0%). The pooled death rate was 10.4% (6.3–16.5%), the pooled treatment failure rate was 9.5% (7.3–12.4%), and the defaulter rate was 14.3% (10.5–19.1%). None of the differences between the two models were statistically significant for any of the outcomes considered. This work improves the quality of the evidence available supporting the World Health Organizations (WHO) recommendation that patients be treated using mainly ambulatory care, conditional on infection control measures in the home and clinic, clinical condition of the patient, availability of treatment support to facilitate adherence to treatment, and provisions for backup facility to manage patients who need inpatient treatment care.Keywords
This publication has 40 references indexed in Scilit:
- A Systematic Review of the Cost and Cost Effectiveness of Treatment for Multidrug-Resistant TuberculosisPharmacoEconomics, 2012
- Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Ambulatory-Based Standardized Therapy for Multi-Drug Resistant Tuberculosis: Experience from Nepal, 2005–2006PLOS ONE, 2009
- Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysisThe Lancet Infectious Diseases, 2009
- Multidrug- and Extensively Drug-Resistant Tuberculosis, GermanyEmerging Infectious Diseases, 2008
- Multidrug-Resistant Tuberculosis Treatment Outcomes in Karakalpakstan, Uzbekistan: Treatment Complexity and XDR-TB among Treatment FailuresPLOS ONE, 2007
- Barriers to successful tuberculosis treatment in Tomsk, Russian Federation: non-adherence, default and the acquisition of multidrug resistance2007
- Feasibility and Cost-Effectiveness of Treating Multidrug-Resistant Tuberculosis: A Cohort Study in the PhilippinesPLOS Medicine, 2006
- Multidrug-resistant Tuberculosis Management in Resource-limited SettingsEmerging Infectious Diseases, 2006
- Treatment outcome of tuberculosis among Saudi nationals: role of drug resistance and complianceClinical Microbiology and Infection, 2003